loading page

Ultrasound guided Core Biopsy with on-site cytology -- immediate diagnosis in pediatric oncology
  • +3
  • boris Sokolovski,
  • michal scolnik,
  • Leonid Malkin,
  • sergey Postovski,
  • shifra ash,
  • Anat Ilivitzki
boris Sokolovski
Rambam Health Care Campus
Author Profile
michal scolnik
Rambam Health Care Campus
Author Profile
Leonid Malkin
Rambam Medical Center
Author Profile
sergey Postovski
Rambam Health Care Campus
Author Profile
shifra ash
Rambam Health Care Campus
Author Profile
Anat Ilivitzki
Rambam Health Care Campus
Author Profile

Abstract

Background: Accurate and swift tissue diagnosis is extremely important for the timely initiation of treatment in pediatric oncology. In our department, ultrasound guided core needle biopsy (US guided CNB) is used for tissue diagnosis. In 2016, we added on-site cytology, allowing for an immediate primary diagnosis. We retrospectively reviewed our performance in terms of safety and accuracy for CNBs and on-site cytology Procedure: All pediatric biopsies performed in our hospital between February 2016, and December 2019 were included. Patient clinical, procedural and follow up data were collected. CNB pathology and cytology results were compared to final pathologic diagnosis. Results: We included 185 patients for which 210 biopsies were performed; Median latency time to biopsy was one day. Altogether, we had 164 tumors, (148 malignant,16 benign) and 46 other lesions. 159 tumors were correctly diagnosed by CNB; five malignant tumors were misdiagnosed as benign. The sensitivity of our US guided CNB is 96.7%, specificity 100%, and accuracy 97.6%. On-site cytology was performed in 41 cases; 36 malignant tumors, 2 benign tumors and 3 reactive lymph nodes. The cytologist correctly differentiated tumor from inflammation in all cases, and diagnosed the precise tumor type in 38 cases, with accuracy of 93% for final diagnosis. We had no complications related to the procedure or sedation. Conclusions: US guided CNB with on-site TI cytology for suspected malignancy in the pediatric population highly available, safe and accurate, with real time diagnosis in most cases. The accelerated diagnostic root has huge impact on patient care.

Peer review status:UNDER REVIEW

14 Sep 2020Assigned to Editor
14 Sep 2020Submission Checks Completed
14 Sep 2020Submitted to Pediatric Blood & Cancer
15 Sep 2020Reviewer(s) Assigned